Pediatric (≤14y) n = 671 | Adult (>14y) n = 147 | P-value | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
0~6m | 7~12m | 1~5y | 6~14y | 15~25y | 26~35y | 36~45y | 46~55y | >56y | |||
Group n(%) 1 | 195 (23.84) | 282 (34.47) | 175 (21.39) | 19 (2.32) | 32 (3.91) | 64 (7.82) | 27 (3.30) | 19 (2.32) | 5 (0.61) | -- | |
Age [M(P25, P75)] | 8m (6, 12m) | 30y (26, 39y) | -- | ||||||||
Male (n, %) 2 | 464 (69.15) | 72 (48.98) | ≤0.05 | ||||||||
Community-onset (n, %) | 649 (96.72) | 135(91.84) | ≤0.05 | ||||||||
Comorbidities (n, %) 2 | 69 (10.28) | 25 (17.01) | ≤0.05 | ||||||||
Congenital heart disease 3 | 33 (4.92) | 3 (2.04) | 0.123 | ||||||||
Diabetes | 1 (0.15) | 6 (4.08) | ≤0.05 | ||||||||
Autoimmune disease 4 | 5 (0.75) | 6 (4.08) | ≤0.05 | ||||||||
Gastrointestinal disease 5 | 9 (1.34) | 0 (0.00) | 0.329 | ||||||||
Neurological diseases 6 | 9 (1.34) | 2 (1.36) | 1.000 | ||||||||
Hepatitis B | 4 (0.60) | 4 (2.72) | 0.056 | ||||||||
Tumour 7 | 3 (0.45) | 2 (1.36) | 0.482 | ||||||||
Others 8 | 5 (0.75) | 2 (1.36) | 0.811 |